Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma [RNA-Seq]
Transcriptional features were detected in NC versus HMGB2-knockout CD8+ T cells of C57BL/6J mice. Overall design: Transcriptional features of NC versus HMGB2-knockout CD8+ T cells in C57BL/6J mice.